These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 20209626)

  • 21. Genetic reductions of beta-site amyloid precursor protein-cleaving enzyme 1 and amyloid-beta ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer's disease model mice.
    Devi L; Ohno M
    Eur J Neurosci; 2010 Jan; 31(1):110-8. PubMed ID: 20092558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presenilin 1 mutants impair the self-renewal and differentiation of adult murine subventricular zone-neuronal progenitors via cell-autonomous mechanisms involving notch signaling.
    Veeraraghavalu K; Choi SH; Zhang X; Sisodia SS
    J Neurosci; 2010 May; 30(20):6903-15. PubMed ID: 20484632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
    Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
    J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interruption of beta-catenin signaling reduces neurogenesis in Alzheimer's disease.
    He P; Shen Y
    J Neurosci; 2009 May; 29(20):6545-57. PubMed ID: 19458225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel GSK-3beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo.
    Serenó L; Coma M; Rodríguez M; Sánchez-Ferrer P; Sánchez MB; Gich I; Agulló JM; Pérez M; Avila J; Guardia-Laguarta C; Clarimón J; Lleó A; Gómez-Isla T
    Neurobiol Dis; 2009 Sep; 35(3):359-67. PubMed ID: 19523516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A three-dimensional human neural cell culture model of Alzheimer's disease.
    Choi SH; Kim YH; Hebisch M; Sliwinski C; Lee S; D'Avanzo C; Chen H; Hooli B; Asselin C; Muffat J; Klee JB; Zhang C; Wainger BJ; Peitz M; Kovacs DM; Woolf CJ; Wagner SL; Tanzi RE; Kim DY
    Nature; 2014 Nov; 515(7526):274-8. PubMed ID: 25307057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hippocampal neurogenesis in the APP/PS1/nestin-GFP triple transgenic mouse model of Alzheimer's disease.
    Zeng Q; Zheng M; Zhang T; He G
    Neuroscience; 2016 Feb; 314():64-74. PubMed ID: 26639620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-cell-autonomous effects of presenilin 1 variants on enrichment-mediated hippocampal progenitor cell proliferation and differentiation.
    Choi SH; Veeraraghavalu K; Lazarov O; Marler S; Ransohoff RM; Ramirez JM; Sisodia SS
    Neuron; 2008 Aug; 59(4):568-80. PubMed ID: 18760694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased hippocampal cell proliferation correlates with increased expression of BMP4 in the APPswe/PS1DeltaE9 mouse model of Alzheimer's disease.
    Li D; Tang J; Xu H; Fan X; Bai Y; Yang L
    Hippocampus; 2008; 18(7):692-8. PubMed ID: 18398851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuron and neuroblast numbers and cytogenesis in the dentate gyrus of aged APP
    Olesen LØ; Sivasaravanaparan M; Severino M; Babcock AA; Bouzinova EV; West MJ; Wiborg O; Finsen B
    Neurobiol Dis; 2017 Aug; 104():50-60. PubMed ID: 28461249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telomere shortening reduces Alzheimer's disease amyloid pathology in mice.
    Rolyan H; Scheffold A; Heinrich A; Begus-Nahrmann Y; Langkopf BH; Hölter SM; Vogt-Weisenhorn DM; Liss B; Wurst W; Lie DC; Thal DR; Biber K; Rudolph KL
    Brain; 2011 Jul; 134(Pt 7):2044-56. PubMed ID: 21672962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endogenous expression of FAD-linked PS1 impairs proliferation, neuronal differentiation and survival of adult hippocampal progenitors.
    Veeraraghavalu K; Choi SH; Zhang X; Sisodia SS
    Mol Neurodegener; 2013 Oct; 8():41. PubMed ID: 24138759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport.
    Sherman MA; LaCroix M; Amar F; Larson ME; Forster C; Aguzzi A; Bennett DA; Ramsden M; Lesné SE
    J Neurosci; 2016 Sep; 36(37):9647-58. PubMed ID: 27629715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of familial Alzheimer's disease-linked human presenilin 1 variants impair enrichment-induced adult hippocampal neurogenesis.
    Veeraraghavalu K; Choi SH; Sisodia SS
    Neurodegener Dis; 2010; 7(1-3):46-9. PubMed ID: 20160458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of microglial activation protects hippocampal neurogenesis and improves cognitive deficits in a transgenic mouse model for Alzheimer's disease.
    Biscaro B; Lindvall O; Tesco G; Ekdahl CT; Nitsch RM
    Neurodegener Dis; 2012; 9(4):187-98. PubMed ID: 22584394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The neurogenic niche in Alzheimer's disease.
    Wander CM; Song J
    Neurosci Lett; 2021 Sep; 762():136109. PubMed ID: 34271133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. L-3-n-Butylphthalide Regulates Proliferation, Migration, and Differentiation of Neural Stem Cell In Vitro and Promotes Neurogenesis in APP/PS1 Mouse Model by Regulating BDNF/TrkB/CREB/Akt Pathway.
    Lei H; Zhang Y; Huang L; Xu S; Li J; Yang L; Wang L; Xing C; Wang X; Peng Y
    Neurotox Res; 2018 Oct; 34(3):477-488. PubMed ID: 29728920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
    Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
    Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.